Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis

Abstract

As discussed in detail in other chapters of this review, chronic hepatitis B (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC). Most HCCs complicate the evolution of an active or inactive cirrhosis. However, some tumors occur on livers with minimal histological changes; the prevalence of such cases varies from one geographical region to the other, being much higher in the southern half of Africa (around 40% of HCCs) than in Asia, America and Europe, where at least 90% of HCCs are associated with the cirrhosis. This heterogeneity is probably a reflection of different environmental and genetic factors. This review will summarize the current knowledge on the mechanisms involved in HBV-related liver carcinogenesis. It will show in particular how viruses can be viewed as tools to discover and dissect new cellular pathways involved in cancer development and emphasize the potential synergistic effects between HBV and hepatitis C virus, as well as between viral infections and other environmental factors, such as alcohol.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

References

  • Ahn JY, Jung EY, Kwun HJ, Lee CW, Sung YC, Jang KL . (2002). J Gen Virol 83: 2765–2772.

  • Andrisani OM, Barnabas S . (1999). Int J Oncol 15: 373–379.

  • Anthony PP . (2001). Histopathology 39: 109–118.

  • Aoki H, Kajino K, Arakawa Y, Hino O . (1996). Proc Natl Acad Sci USA 93: 7300–7304.

  • Arbuthnot P, Capovilla A, Kew M . (2000). J Gastroenterol Hepatol 15: 357–368.

  • Bannasch P, Enzmann H, Hacker HJ . (1989) In: Bannasch P, Keppler D, Weber G (eds). Liver Cell Carcinoma. Kluwer Academic Publishers: Germany, pp 55–78.

    Google Scholar 

  • Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A et al. (1999). Oncogene 18: 2860–2871.

  • Bergametti F, Sitterlin D, Transy C . (2002). J Virol 76: 6495–6501.

  • Bouchard MJ, Puro RJ, Wang L, Schneider RJ . (2003). J Virol 77: 7713–7719.

  • Bouchard MJ, Schneider RJ . (2004). J Virol 78: 12725–12734.

  • Bouchard MJ, Wang LH, Schneider RJ . (2001). Science 294: 2376–2378.

  • Bréchot C . (1998) In: Rizzetto M, Purcell RH, Gerin JL, Verme (eds). Viral Hepatitis and Liver Disease. Edizioni Minerva Medica: Rome, pp 490–508.

    Google Scholar 

  • Brechot C, Gozuacik D, Murakami Y, Paterlini-Brechot P . (2000). Semin Cancer Biol 10: 211–231.

  • Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P . (2001). Hepatology 34: 194–203.

  • Bruni R, D'Ugo E, Giuseppetti R, Argentini C, Rapicetta M . (1999). Virology 257: 483–490.

  • Bruni R, D'Ugo E, Villano U, Fourel G, Buendia MA, Rapicetta M . (2004). Virology 329: 1–10.

  • Buendia MA . (1994) In: Christian B (ed). Primary Liver Cancer: Etiological and Progression Factors. CRC Press: Paris. pp 211–224.

    Google Scholar 

  • Cha MY, Kim CM, Park YM, Ryu WS . (2004). Hepatology 39: 1683–1693.

  • Chami M, Gozuacik D, Saigo K, Capiod T, Falson P, Isono K et al. (2000). Oncogene 19: 2877–2886.

  • Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW et al. (2004). Gut 53: 1494–1498.

  • Chen C, Diani A, Brown P, Kaluzny M, Epps D . (1986). Br J Exp Pathol 67: 1868.

  • Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN et al. (2006). JAMA 295: 65–73.

  • Chen GG, Li MY, Ho RL, Chak EC, Lau WY, Lai PB . (2005a). J Clin Virol 34: 7–12.

  • Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC et al. (1993). J Virol 67: 1218–1226.

  • Chen Y, Wei H, Sun R, Tian Z . (2005b). Int Immunopharmacol 5: 1839–1852.

  • Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C et al. (1997). Proc Natl Acad Sci USA 94: 8162–8167.

  • Chisari FV . (1995). Hepatology 22: 1316–1325.

  • Choi Y, Gyoo Park S, Yoo JH, Jung G . (2005). Virology 332: 454–463.

  • Chun E, Lee J, Cheong HS, Lee KY . (2003). J Immunol 170: 1183–1190.

  • Chung MK, Yoon H, Min SS, Lee HG, Kim YJ, Lee TG et al. (1999). J Immunother 22: 279–287.

  • Chung TW, Lee YC, Kim CH . (2004). FASEB J 18: 1123–1125.

  • Clementi M, Manzin A, Paolucci S, Menzo S, Bangarelli P, Carloni G et al. (1993). Res Virol 144: 297–301.

  • Collier LS, Carlson CM, Ravimohan S, Dupuy AJ, Largaespada DA . (2005). Nature 436: 272–276.

  • Cui F, Wang Y, Wang J, Wei K, Hu J, Liu F et al. (2006). Proteomics 6: 498–504.

  • Diao J, Garces R, Richardson CD . (2001). Cytokine Growth Factor Rev 12: 189–205.

  • Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J et al. (2005). Mol Cell 19: 159–170.

  • Donato F, Boffetta P, Puoti M . (1998). Int J Cancer 75: 347–354.

  • Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP et al. (1997). Proc Natl Acad Sci USA 94: 14707–14712.

  • Fan YF, Lu CC, Chang YC, Chang TT, Lin PW, Lei HY et al. (2000). J Gastroenterol Hepatol 15: 519–528.

  • Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT et al. (2001). Hepatology 33: 277–286.

  • Farza H, Dragani TA, Metzler T, Manenti G, Tiollais P, Della Porta G et al. (1994). Mol Carcinogen 9: 185–192.

  • Feitelson MA . (2005). Cancer Lett, September 2005 [E-pub ahead of print].

  • Feitelson MA, Zhu M, Duan LX, London WT . (1993). Oncogene 8: 1109–1117.

  • Ferber MJ, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC et al. (2003). Oncogene 22: 3813–3820.

  • Galloway DA, McDougall JK . (1983). Nature 302: 21–24.

  • Gerin J, Cote P, Korba B, Miller R, Purcell R, Tennant B . (1991) In: Hollinger FB, Lemon SM, Margolis H (eds). Viral Hepatitis and Liver Disease. Williams and Wilkins: Baltimore. pp 556–559.

    Google Scholar 

  • Gong SS, Jensen AD, Rogler CE . (1996). J Virol 70: 2000–2007.

  • Guidotti LG, Borrow P, Brown A, McClary H, Koch R, Chisari FV . (1999a). J Exp Med 189: 1555–1564.

  • Guidotti LG, Chisari FV . (2000). Virology 273: 221–227.

  • Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV . (1999b). Science 284: 825–829.

  • Günther S, Sommer G, Iwanska A, Will H . (1997). Virology 238: 363–371.

  • Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM et al. (1994). Med Sci 91: 12808–12812.

  • Haller O, Frese M, Kochs G . (1998). Rev Sci Tech 17: 220–230.

  • Han KH, Hollinger FB, Noonan CA, Solomon H, Klintmalm GB, Genta RM et al. (1993). Hepatology 18: 1032–1038.

  • Henkler F, Hoare J, Waseem N, Goldin RD, McGarvey MJ, Koshy R et al. (2001). J Gen Virol 82: 871–882.

  • Hess J, Stemler M, Will H, Schroder CH, Kuhn J, Braun R . (1988). Med Microbiol Immunol (Berl) 177: 195–205.

  • Hessein M, Saad el G, Mohamed AA, Kamel el AM, Abdel Hady AM, Amina M et al. (2005). Tumori 91: 241–247.

  • Hino O, Kajino K, Umeda T, Arakawa Y . (2002). J Gastroenterol 37: 883–887.

  • Horikawa I, Barrett JC . (2001). J Natl Cancer Inst 93: 1171–1173.

  • Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD et al. (2004). Carcinogenesis 25: 2023–2032.

  • Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ . (1999). J Virol 73: 7231–7240.

  • Hui AY, Sung JJ . (2005). Curr Opin Infect Dis 18: 400–406.

  • Hung L, Kumar V . (2004). FEBS Lett 560: 210–214.

  • Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, Zhong ZH et al. (2003). J Clin Microbiol 41: 5449–5455.

  • Hwang GY, Lin CY, Huang LM, Wang YH, Wang JC, Hsu CT et al. (2003). J Clin Microbiol 41: 5598–5603.

  • Hwang YK, Kim NK, Park JM, Lee K, Han WK, Kim HI et al. (2002). Vaccine 20: 3770–3777.

  • Iavarone M, Trabut JB, Delpuech O, Carnot F, Colombo M, Kremsdorf D et al. (2003). J Hepatol 39: 253–261.

  • Kalra N, Kumar V . (2004). J Biol Chem 279: 25313–25319.

  • Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M et al. (1997). Int J Cancer 71: 355–359.

  • Kao JH, Chen PJ, Lai MY, Chen DS . (2003). Gastroenterology 124: 327–334.

  • Kim DG . (2005). Methods Mol Biol 317: 141–156.

  • Kim JH, Kang S, Kim J, Ahn BY . (2003). J Virol 77: 7166–7173.

  • Kim KH, Seong BL . (2003). EMBO J 22: 2104–2116.

  • Klein NP, Bouchard MJ, Wang LH, Kobarg C, Schneider RJ . (1999). EMBO J 18: 5019–5027.

  • Kojiro M, Roskams T . (2005). Semin Liver Dis 25: 133–142.

  • Koo JS, Seong JK, Park C, Yu DY, Oh BK, Oh SH et al. (2005). Intervirology 48: 16–22.

  • Korba BE, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H et al. (1989). Hepatology 9: 461–470.

  • Koziel MJ . (1999). Semin Liver Dis 19: 157–169.

  • Kuang SY, Jackson PE, Wang JB, Lu PX, Munoz A, Qian GS, Kensler TW et al. (2004). Proc Natl Acad Sci USA 101: 3575–3580.

  • Kwun HJ, Jang KL . (2004). Nucleic Acids Res 32: 2202–2213.

  • Lakhtakia R, Kumar V, Reddi H, Mathur M, Dattagupta S, Panda SK . (2003). J Gastroenterol Hepatol 18: 80–91.

  • Larkin J, Clayton M, Sun B, Perchonock CE, Morgan JL, Siracusa LD et al. (1999). Nat Med 5: 907–912.

  • Lee AT, Ren J, Wong ET, Ban KH, Lee LA, Lee CG . (2005a). J Biol Chem 280: 33525–33535.

  • Lee JO, Kwun HJ, Jung JK, Choi KH, Min do S, Jang KL . (2005b). Oncogene 24: 6617–6625.

  • Lee MO, Choi YH, Shin EC, Kang HJ, Kim YM, Jeong SY et al. (2002). J Hepatol 37: 380–386.

  • Lee SW, Lee YM, Bae SK, Murakami S, Yun Y, Kim KW . (2000). Biochem Biophys Res Commun 268: 456–461.

  • Lee YI, Hwang JM, Im JH, Kim NS, Kim DG, Yu DY et al. (2004). J Biol Chem 279: 15460–15471.

  • Leon B, Taylor L, Vargas M, Luftig RB, Albertazzi F, Herrero L et al. (2005). Virol J 2: 60.

  • Leupin O, Bontron S, Schaeffer C, Strubin M . (2005). J Virol 79: 4238–4245.

  • Leupin O, Bontron S, Strubin M . (2003). J Virol 77: 6274–6283.

  • Levrero M, Stemler M, Pasquinelli C, Alberti A, Jean-Jean O, Franco A et al. (1991). Hepatology 13: 143–149.

  • Li D, Chen X, Zhang W . (2003). J Huazhong Univ Sci Technol Med Sci 23: 383–386.

  • Li J, Shen H, Himmel K, Dupuy A, Largaespada D, Nakamura T . (1999). Nat Genet 23: 348–353.

  • Lin X, Xu X, Huang QL, Liu YQ, Zheng DL, Chen WN et al. (2005). World J Gastroenterol 11: 4703–4708.

  • Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S . (1997). Cancer Res 57: 5137–5142.

  • Loncarevic I, Schrantz P, Zentgraf H, Liang X, Herrman G, Tang Z et al. (1990). Virology 174: 158–168.

  • Lugassy C, Bernuau J, Thiers V, Krosgaard K, Degott C, Wantzin P et al. (1987). J Infect Dis 155: 64–71.

  • Madden CR, Finegold MJ, Slagle BL . (2001). J Virol 75: 3851–3858.

  • Malmassari S, Lone YC, Zhang M, Transy C, Michel ML . (2005). Microbes Infect 7: 626–634.

  • Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky EA . (2004). Mutat Res 554: 305–318.

  • McMahon BJ . (2005). Semin Liver Dis 25 (Suppl 1): 3–8.

  • Melegari M, Wolf SK, Schneider RJ . (2005). J Virol 79: 9810–9820.

  • Miao J, Chen GG, Chun SY, Lai PP . (2005). Cancer Lett, 28 June 2005 [E-pub ahead of print].

  • Minami M, Daimon Y, Mori K, Takashima H, Nakajima T, Itoh Y et al. (2005). Oncogene 24: 4340–4348.

  • Minami M, Poussin K, Kew M, Okanoue T, Bréchot C, Paterlini P . (1996). Gastroenterology 111: 691–700.

  • Moon EJ, Jeong CH, Jeong JW, Kim KR, Yu DY, Murakami S et al. (2004). FASEB J 18: 382–384.

  • Moradpour D, Blum HE . (2005). Eur J Gastroenterol Hepatol 17: 477–483.

  • Morgan D, Pecararo G, Rosenberg I, Defendi V . (1990). J Virol 64: 969–976.

  • Murakami Y, Minami M, Daimon Y, Okanoue T . (2004). J Med Virol 72: 203–214.

  • Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Brechot C et al. (2005). Gut 54: 1162–1168.

  • Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV . (1998). J Exp Med 188: 341–350.

  • Oon CJ, Chen WN, Goh KT, Mesenas S, Ng HS, Chiang G et al. (2002). J Gastroenterol Hepatol 17 (Suppl): S491–S496.

  • Orito E, Mizokami M . (2003). Intervirology 46: 408–412.

  • Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T et al. (2001). Hepatology 33: 218–223.

  • Pang R, Tse E, Poon RT . (2005). Cancer Lett, 17 October 2005 [E-pub ahead of print].

  • Paradis V, Laurendeau I, Vidaud M, Bedossa P . (1998). Hepatology 28: 953–958.

  • Paterlini-Brechot P, Saigo K, Murakami Y, Chami M, Gozuacik D, Mugnier C et al. (2003). Oncogene 22: 3911–3916.

  • Paterlini P, Driss F, Pisi E, Franco D, Berthelot P, Bréchot C . (1993). Hepatology 17: 20–29.

  • Paterlini P, Poussin K, Kew M, Franco D, Bréchot C . (1995). Hepatology 21: 313–321.

  • Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F et al. (2005). Int J Oncol 26: 467–473.

  • Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Crax A et al. (2004). Gastroenterology 126: 102–110.

  • Pontisso P, Poon MC, Tiollais P, Bréchot C . (1984). BMJ 288: 1563–1566.

  • Poussin K, Diennes H, Sirma H, Urban S, Beaugrand M, Schirmacher P et al. (1999). Int J Cancer 80: 497–505.

  • Pujol FH, Devesa M . (2005). J Clin Gastroenterol 39: 611–618.

  • Rahmani Z, Huh KW, Lasher R, Siddiqui A . (2000). J Virol 74: 2840–2846.

  • Raimondo G, Burk R, Lieberman H, Muschel J, Hadziyannis S, Will H et al. (1988). Virology 166: 103–112.

  • Reifenberg K, Nusser P, Lohler J, Spindler G, Kuhn C, von Weizsacker F et al. (2002). J Gen Virol 83: 991–996.

  • Robek MD, Wieland SF, Chisari FV . (2002). J Virol 76: 3570–3574.

  • Roberts LR, Gores GJ . (2005). Semin Liver Dis 25: 212–225.

  • Romero R, Lavine JE . (1996). Hepatology 23: 17–23.

  • Rosmorduc O, Petit M-A, Pol S, Capel F, Bortolotti F, Berthelot P et al. (1995). Hepatology 22: 10–19.

  • Rosmorduc O, Sirma H, Soussan P, Gordien E, Lebon P, Horisberger M et al. (1999). J Gen Virol 80: 1253–1262.

  • Sanchez-Prieto R, de Alava E, Palomino T, Guinea J, Fernandez V, Cebrian S et al. (1999). Nat Med 5: 1076–1079.

  • Schluter V, Meyer M, Hofschneider PH, Koshy R, Caselmann WH . (1994). Oncogene 9: 3335–3344.

  • Sell S . (1993). Int J Dev Biol 37: 189–201.

  • Shin EC, Shin JS, Park JH, Kim H, Kim SJ . (1999). Int J Cancer 82: 587–591.

  • Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C . (1999). Oncogene 18: 4848–4859.

  • Sirma H, Weil R, Rosmorduc O, Urban S, Israel A, Kremsdorf D et al. (1998). Oncogene 16: 2051–2063.

  • Sitterlin D, Bergametti F, Transy C . (2000). Oncogene 19: 4417–4426.

  • Smith KT, Campo MS . (1988). Virology 64: 39–47.

  • Soussan P, Garreau F, Zylberberg H, Ferray C, Brechot C, Kremsdorf D . (2000). J Clin Invest 105: 55–60.

  • Soussan P, Tuveri R, Nalpas B, Garreau F, Zavala F, Masson A et al. (2003). J Hepatol 38: 343–348.

  • Su Q, Schroder CH, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P . (1998). Hepatology 27: 1109–1120.

  • Takada S, Shirakata Y, Kaneniwa N, Koike K . (1999). Oncogene 18: 6965–6973.

  • Tamori A, Nishiguchi S, Kubo S, Koh N, Moriyama Y, Fujimoto S et al. (1999). Hepatology 29: 1429–1434.

  • Tamori A, Yamanishi Y, Kawashima S, Kanehisa M, Enomoto M, Tanaka H et al. (2005). Clin Cancer Res 11: 5821–5826.

  • Tanaka Y, Kanai F, Kawakami T, Tateishi K, Ijichi H, Kawabe T et al. (2004). Biochem Biophys Res Commun 318: 461–469.

  • Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F et al. (2005). J Virol 79: 5548–5556.

  • Tennant BC, Toshkov IA, Peek SF, Jacob JR, Menne S, Hornbuckle WE et al. (2004). Gastroenterology 127: S283–S293.

  • Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P et al. (1997). Oncogene 14: 395–404.

  • Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P et al. (1998). Oncogene 17: 2115–2123.

  • Terré S, Petit MA, Bréchot C . (1991). J Virol 65: 5539–5543.

  • Toshkov I, Chisari FV, Bannasch P . (1994). Hepatology 20: 1162–1172.

  • Tralhao JG, Roudier J, Morosan S, Giannini C, Tu H, Goulenok C et al. (2002). Proc Natl Acad Sci USA 99: 6991–6996.

  • Transy C, Fourel G, Robinson WS, Tiollais P, Marion PL, Buendia MA . (1992). Proc Natl Acad Sci USA 89: 3874–3878.

  • Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M et al. (2001). Cancer Res 61: 7803–7810.

  • Wang HC, Chang WT, Chang WW, Wu HC, Huang W, Lei HY et al. (2005). Hepatology 41: 761–770.

  • Wang W, London T, Feitelson MA . (1991). Cancer Res 51: 4971–4977.

  • Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C et al. (2004a). Hepatology 39: 318–324.

  • Wang Y, Lau SH, Sham JS, Wu MC, Wang T, Guan XY . (2004b). Oncogene 23: 142–148.

  • Xu Z, Yen TS, Wu L, Madden CR, Tan W, Slagle BL et al. (2002). J Virol 76: 2579–2584.

  • Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF . (2000). Oncogene 19: 5213–5220.

  • Yoo YG, Cho S, Park S, Lee MO . (2004). FEBS Lett 577: 121–126.

  • Yoo YG, Lee MO . (2004). J Biol Chem 279: 36242–36249.

  • Yoo YG, Oh SH, Park ES, Cho H, Lee N, Park H et al. (2003). J Biol Chem 278: 39076–39084.

  • Yotsuyanagi H, Hino K, Tomita E, Toyoda J, Yasuda K, Iino S . (2002). J Hepatol 37: 355–363.

  • Yu FL, Liu HJ, Lee JW, Liao MH, Shih WL . (2005). J Hepatol 42: 520–527.

  • Zhang JL, Zhao WG, Wu KL, Wang K, Zhang X, Gu CF et al. (2005a). Arch Virol 150: 721–741.

  • Zhang SM, Sun DC, Lou S, Bo XC, Lu Z, Qian XH et al. (2005b). Arch Virol 150: 1579–1590.

  • Zhang Z, Protzer U, Hu Z, Jacob J, Liang TJ . (2004). J Virol 78: 4566–4572.

  • Zhu H, Wang Y, Chen J, Cheng G, Xue J . (2004). Exp Mol Pathol 76: 44–50.

  • Ziemer M, Garcia P, Shaul Y, Rutter WJ . (1985). J Virol 53: 885–892.

  • Zoulim F, Saputelli J, Seeger C . (1994). J Virol 68: 2026–2030.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Brechot.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kremsdorf, D., Soussan, P., Paterlini-Brechot, P. et al. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 25, 3823–3833 (2006). https://doi.org/10.1038/sj.onc.1209559

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209559

Keywords

  • hepatocellular carcinoma
  • hepatitis B virus
  • viral integration
  • HBx
  • HBSP

Further reading

Search

Quick links